QC/QA - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

QC/QA

EMA Releases Pharmacovigilance Meeting Highlights

October 10, 2014

The European Medicines Agency releases highlights from its Pharmacovigilance Risk Assessment Committee safety review meeting in October.

FDA Releases REMS Report

September 25, 2014

FDA report details risk mitigation projects.

Baxter Recalls Peritoneal Dialysis Solution

August 15, 2014

Baxter voluntarily recalls two lots of peritoneal dialysis solution because of the presence of particulate matter.

Cubist Pharmaceuticals Recalls CUBICIN

August 8, 2014

Cubist Pharmaceuticals voluntarily recalls certain lots of CUBICIN 500 mg in 10 mL single-use vials because of the presence of particulate matter.

Acute Need for Supply Chain Transparency

August 4, 2014

PTSM: Pharmaceutical Technology Sourcing and Management

Biopharma manufacturers must reduce the risk in their complex supply chains

One Step Back, Two Steps Forward to Improved Quality Processes

May 8, 2014

Life-sciences companies can get a jump on potential quality problems by looking at the leading indicators hiding in the document management process further upstream.

Innovations Abound

July 2, 2007
Pharmaceutical Technology

Here's a look at some of the most interesting and thematic responses you—our readers—provided for Pharmaceutical Technology's anniversary survey of industry advances and directions.

Signature Authentication Can Restore Confidence

June 2, 2007

Pharmaceutical Technology

Signature authentication technology has evolved to become a stong tool for improving confidence in verification.

ExcipientFest Attendees Discuss Regulatory and Quality Concerns

April 27, 2007

ePT--the Electronic Newsletter of Pharmaceutical Technology

San Juan, PR (Apr. 25)-Regulatory and quality issues were prominent discussion topics at this year?s ExcipientFest conference and exhibition.

ADVERTISEMENT

LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
What role should the US government play in the current Ebola outbreak?
Finance development of drugs to treat/prevent disease.
Oversee medical treatment of patients in the US.
Provide treatment for patients globally.
All of the above.
No government involvement in patient treatment or drug development.
Finance development of drugs to treat/prevent disease.
28%
Oversee medical treatment of patients in the US.
9%
Provide treatment for patients globally.
9%
All of the above.
41%
No government involvement in patient treatment or drug development.
13%
Jim Miller Outsourcing Outlook Jim MillerCMO Industry Thins Out
Cynthia Challener, PhD Ingredients Insider Cynthia ChallenerFluorination Remains Key Challenge in API Synthesis
Marilyn E. Morris Guest EditorialMarilyn E. MorrisBolstering Graduate Education and Research Programs
Jill Wechsler Regulatory Watch Jill Wechsler Biopharma Manufacturers Respond to Ebola Crisis
Sean Milmo European Regulatory WatchSean MilmoHarmonizing Marketing Approval of Generic Drugs in Europe
Click here